Giulio Rizzoli added an update.
Twenty year patient survival and 17 year complications of isolated Mitral Biocor Standard porcine prosthesis
Rizzoli G, Bottio T, Comisso M, Faggian G, Milano A, et al. (2J Clin Exp Cardiolog 8:508, 2017 . doi: 10.4172/2155-9880.1000508
This is my latest work forgotten in a drawer at the time of my retirement, I have rearranged and published this year. It was well judged by many reviewers and readers but I want to emphasize a point of discussion which is of public interest, therefore i reproduce a paragraph of the paper discussion: "A large series has been recently published from Myken in Finland. Finland and Italy are both founded on a public health service and committed to high quality data, nonetheless we must complain that Italian citizens and statistical data repositories oppose resistance to share individual data with researchers because of “privacy” issues and legislation [13 Ichino Andrea (2005) L’ISTAT che vorremmo. (the national statistic institute we would like to have) La Voce ] In this reference the economy professor Ichino writes: ”It's a matter of democracy and transparency: the scientific community must have access to microdata to check and replicate the results. Some might think that only economists have these needs. It's not like that. The heart surgeon Gulio Rizzoli says: Among the obstacles that our countr imposes on scientific progress we include the recent adoption of privacy regulations that prevent ISTAT to allow us to view the death reports of our patients, recorded by our colleagues. The investigation of the mode or cause of death is essential to understand the risks associated with the use of new biomedical technologies, valves included. In our case it must answer the question if death was due to cardiac causes, to complications of prosthesis or to cardiac unrelated disease/event.This is a particularly significant example of the fact that privacy cannot be considered an absolute good. The data that Rizzoli cannot obtain would provide essential information to improve cardiosurgical therapies with positive effects for the whole nation".
In the age of genomics the new paradigm of medicine is offering personalized treatments for each patient, likewise medical statistics must individualize the evaluation of the results based on the constellation of risk factors individual patient. We rely more often on searches coming from the USA that has predominantly private health care. I believe that, when health is provided, from the state, thanks to taxes payed from the citizens, as in our system, there is a moral obligation of the ill to allow the experience gained during his own treatment to be used to increase the healing chances of others, occasionaly an his own relative. At the contrary, the law of privacy, which is frequently circumvented from gossip, very efficiently hinders the capabability of surgeons to monitor the outcomes of their operations.
The paper is a free pdf, it is available in internet and can be downloaded from the OPEN ACCESS publishing journal: Clinical & Experimental Cardiology